Spiro Rombotis
Vorstandsvorsitzender bei CYCLACEL PHARMACEUTICALS, INC.
Vermögen: 109 853 $ am 30.04.2024
Aktive Positionen von Spiro Rombotis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CYCLACEL PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.03.2006 | - |
Vorstandsvorsitzender | 01.08.1997 | - | |
Präsident | 01.08.1997 | - | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Direktor/Vorstandsmitglied | 20.05.2010 | - |
Karriereverlauf von Spiro Rombotis
Ehemalige bekannte Positionen von Spiro Rombotis
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cyclacel Group Plc
Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Präsident | 01.08.1997 | 15.10.2008 |
NOVARTIS AG | Corporate Officer/Principal | - | - |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Vertrieb & Marketing | - | - |
BRISTOL-MYERS SQUIBB COMPANY | Vertrieb & Marketing | - | - |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Geschäftsführer | - | - |
Ausbildung von Spiro Rombotis
Williams College | Undergraduate Degree |
Kellogg School of Management | Graduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Vereinigtes Königreich | 2 |
Schweiz | 2 |
Operativ
President | 2 |
Director/Board Member | 2 |
Sales & Marketing | 2 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
CYCLACEL PHARMACEUTICALS, INC. | Health Technology |
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
NOVARTIS AG | Health Technology |
Private Unternehmen | 4 |
---|---|
Cyclacel Group Plc
Cyclacel Group Plc Pharmaceuticals: MajorHealth Technology Cyclacel Group Plc designs and develops small molecule drugs. The company developed small molecule drugs act on key cell cycle regulators to stop uncontrolled cell division in cancer and other diseases involving abnormal cell proliferation. Cyclacel Group Plc was founded by Professor Sir David Lane in 1996 and is headquartered in Dundee, UK. | Health Technology |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
- Börse
- Insiders
- Spiro Rombotis
- Erfahrung